Sweden· SE-20120127000012
Hyprosan 3,2 mg/ml Ögondroppar, lösning
A medicinal product containing hypromellose, registered in Sweden by Santen Oy.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Hypromellose
- Manufacturer
- Santen Oy
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120127000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hypromellose in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsArtelac EDO 3,2 mg/ml oogdruppels, oplossingMedcor Pharmaceuticals B.V.
- PolandArtelacInPharm Sp. z o.o.
- NorwayArtelacBAUSCH + LOMB IRELAND LIMITED
- BelgiumArtelac 3,2 mg/mlBausch & Lomb Pharma
- IrelandArtelac 3.2 mg/ml Eye Drops, SolutionBausch + Lomb Ireland Limited
- IcelandHyprosanSanten Oy
- FranceARTELAC 1,6 mg/0,5 mL, collyre en récipient unidoseLABORATOIRE CHAUVIN
- FinlandHyprosanSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Hypromellose Agepha, Prosicca
- Bulgaria · Артелак, Кристал Вижън
- Germany · Artelac, Artelac Edo
- Denmark · Artelac, Hyprosan
- Estonia · Artelac, Hyprosan
- Spain · Artific
- Finland · Artelac, Hyprosan
- France · Artelac
- United Kingdom (Northern Ireland) · Hypromellose Fdc International, Hypromellose Martindale Pharmaceuticals
- Greece · Lubrilac, Vidilac
- Ireland · Artelac, Artelac Preservative Free Single Dose Unit
- Iceland · Hyprosan
- Lithuania · Artelac
- Luxembourg · Artelac, Artelac Edo
- Netherlands · Artelac, Artelac Edo
- Norway · Artelac, Hyprosan
- Portugal · Davilose, Davilose Forte
- Slovenia · Artelac, Artelac Uno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f05f6466-2c23-4d07-8bd8-32e647ab27b0 GET /v1/drugs/f05f6466-2c23-4d07-8bd8-32e647ab27b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"PAR",
"SmPC"
],
"se_npl_id": "20120127000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120127000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Hyprosan%20eye-drops%2C%20solution%20ENG%20SmPC_09001bee807a3a6b.pdf"
}See everything about hypromellose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.